Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2026
EBV-Positive Classic Hodgkin Lymphoma and Primary Nodal T-Cell/NK-Cell Lymphoma Arising in the Background of Follicular Lymphoma.
Journal: Case reports in hematology
Published: April 08, 2024
Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: February 08, 2024
[89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model.
Journal: Molecular imaging and biology
Published: June 19, 2019
Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 21, 2017
ImmunoPET of Malignant and Normal B Cells with 89Zr- and 124I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 24, 2017
Engineering A11 Minibody-Conjugated, Polypeptide-Based Gold Nanoshells for Prostate Stem Cell Antigen (PSCA)-Targeted Photothermal Therapy.
Journal: SLAS technology
Published: September 24, 2016
Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 02, 2015
Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 19, 2014
Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 05, 2014
A mutated anti-CA19-9 scFv-Fc for positron emission tomography of human pancreatic cancer xenografts.
Journal: Molecular imaging and biology
Published: April 03, 2014
Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 08, 2014
Last Updated: 09/26/2026